By Emily Field ( September 7, 2016, 11:21 PM EDT) -- Consumers on Wednesday pushed the Ninth Circuit to revive state-law claims that Merck and other drugmakers failed to warn them of pancreas problems from Type 2 diabetes drugs, saying that a lower court's erroneous interpretation of a U.S. Supreme Court ruling sent the entire multidistrict litigation off-track....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.